Pharmacy News

Fentanyl tablet seizures have quadrupled in 6 years

Law enforcement seizures of illicit fentanyl increased dramatically in number and size between 2017 and 2023 in the United States, especially in tablet form, according to a new study funded by the NIH National Institute on Drug Abuse. The findings, published online in International Journal of Drug Policy on May 13, 2024, highlight the illicit drug supply and the risk of tablets not coming from a pharmacy.

Coming off GLP-1s slowly could be key to preventing weight regain

Despite concerns about patients regaining weight after stopping GLP-1 receptor agonists like semaglutide and tirzepatide, new research suggests that such gains aren’t necessarily the case. The key, the findings suggest, lies in gradually weaning off the drug instead of withdrawing abruptly and completely, and then continuing to make healthy choices.

For smoking cessation, increasing dose may help improve abstinence

Most people who smoke don’t quit on their initial attempt. What’s the best course of action, then, if an initial smoking cessation attempt fails? Results from a randomized clinical trial published in JAMA Network found that for individuals who did not quit after being treated with varenicline, increasing the dosage enhanced abstinence. For nonabstainers who were initially treated with combination nicotine replacement therapy, a dosage increase or a switch to varenicline enhanced abstinence.

Under new law, pharmacist scope of practice expands in Tennessee

Governor Bill Lee of Tennessee signed legislation that expands pharmacists’ scope of practice in the state. The law took effect immediately upon the governor’s signature on May 1.

AHA wants to engage pharmacists in AFib care

A new initiative from the American Heart Association (AHA) aims to educate and engage pharmacists in caring for patients with AFib.